OneMedNet shares surge 13.61% after-hours on Palantir partnership boosting AI and healthcare data growth.

OneMedNet surged 13.61% in after-hours trading following multiple developments enhancing its healthcare data capabilities. The stock’s rise coincided with news of a new partnership with Palantir, expanding its AI and healthcare data footprint, alongside the addition of 85 cardiovascular centers and 2.7 million annual cardiovascular studies to its network. These developments, announced on August 20, 2025, underscored OneMedNet’s growth in real-world data offerings and strategic collaborations, fueling bullish sentiment ahead of earnings. Earlier in the month, a partnership with Inka Health for AI-driven oncology projects and a subscription revenue model with Circle CVI further reinforced its commercial expansion. Combined with a 80% debt reduction reported on August 14 and a 25% network expansion in July, these factors positioned the company for improved growth prospects in AI-powered healthcare analytics.